Division of Cardiology, The Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Cardiovascular Disease, University of Virginia, Charlottesville, VA, USA.
J Cardiovasc Comput Tomogr. 2022 Mar-Apr;16(2):138-149. doi: 10.1016/j.jcct.2021.09.004. Epub 2021 Oct 8.
Our understanding of sex differences in subclinical atherosclerosis and plaque composition and characteristics have greatly improved with the use of coronary computed tomography (CCTA) over the past years. CCTA has emerged as an important frontline diagnostic test for women, especially as we continue to understand the impact of non-obstructive atherosclerosis as well as diffuse, high risk plaque as precursors of acute cardiac events in women. Based on its ability to identify complex plaque morphology such as low attenuation plaque, high risk non calcified plaque, positive remodeling, fibrous cap, CCTA can be used to assess plaque characteristics. CCTA can avoid false positive of other imaging studies, if included earlier in assessment of ischemic symptoms. In the contemporary clinical setting, CCTA will prove useful in further understanding and managing cardiovascular disease in women and those without traditional obstructive coronary disease.
近年来,随着冠状动脉计算机断层扫描(CCTA)的应用,我们对亚临床动脉粥样硬化和斑块成分及特征的性别差异有了更深入的了解。CCTA 已经成为女性的重要一线诊断测试,尤其是随着我们继续了解非阻塞性动脉粥样硬化以及弥漫性、高危斑块作为女性急性心脏事件的前兆的影响。基于其识别复杂斑块形态的能力,如低衰减斑块、高危非钙化斑块、正性重构、纤维帽,CCTA 可用于评估斑块特征。如果在评估缺血症状时更早地进行 CCTA 检查,可以避免其他影像学研究的假阳性结果。在当代临床环境中,CCTA 将有助于进一步了解和管理女性和非传统阻塞性冠心病患者的心血管疾病。